MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

484933

Report Date :

09.01.2018

 

IDENTIFICATION DETAILS

 

Name :

MEDLEY PHARMACEUTICALS LIMITED (w.e.f. 30.06.1996)

 

 

Formerly Known As :

MEDLEY PHARMACEUTICALS PRIVATE LIMITED

 

 

Registered Office :

Medley Housed, D-2, M.I.D.C. Area, 16th Road, Andheri (East), Mumbai – 400093, Maharashtra

Tel. No.:

91 - 22 - 30887777, 30888981

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

15.04.1975

 

 

Com. Reg. No.:

11-018296

 

 

Capital Investment / Paid-up Capital :

INR 319.370 Million

 

 

CIN No.:

[Company Identification No.]

U24230MH1975PLC018296

 

 

IEC No.:

0391007807

 

 

GSTIN:

Not Divulged

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMM21128C

 

 

PAN No.:

[Permanent Account No.]

AAACM2764J

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturers of dealers in and exporters and importers of all kinds of Pharmaceutical products, drugs, and medical products. (Registered Activity)

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A+

 

Credit Rating

Explanation

Rating Comments

A+

Low Risk

Business dealings permissible with low risk of default

 

Maximum Credit Limit :

USD 9200000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Exists

 

 

Comments :

Subject was incorporated in the year 1975. It is a manufacturer, dealer, exporter and importer of pharmaceutical products, drugs and medical products.

 

As per the financial of 2017, the company has achieved a fair. Growth of 10.52% in its revenue as compared to the previous year and has earned a favourable net profit margin of 9.00%.

 

The company possesses strong financial profile marked by sound net worth base along with low debt balance sheet profile and comfortable liquidity parameters.

 

Business is active. Payments are reported to be regular and as per commitment.

 

In view of aforesaid, the company can be considered for business dealings at usual trade terms and conditions. 

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.06.2017)

Current Rating

(30.09.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long term Loans (A+)

Rating Explanation

Adequate degree of safety and low credit risk.

Date

31.10.2017

 

Rating Agency Name

CRISIL

Rating

Short Term Loans (A1)

Rating Explanation

Very strong degree of safety and carry lowest credit risk.

Date

31.10.2017

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 09.01.2018

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

 

LOCATIONS

 

Registered Office :

Medley Housed, D-2, M.I.D.C. Area, 16th Road, Andheri (East), Mumbai – 400093, Maharashtra, India

Tel. No.:

91-22-30887777, 30888981

Fax No.:

91-22-28204453

E-Mail :

sahir@medleylab.com

mail@medleylab.com

api@medleylab.com
collaboration@medleylab.com

contract@medleylab.com

inlicensing@medleylab.com

Website :

https://www.medleylab.com

 

 

Factory  1:

Lane No-03, Phase- 1, SIDCO Industrial Estate, Bari Brahmana, Jammu- 181133, Jammu and Kashmir, India

Tel. No.:

91-1923-220749

 

 

Factory  2:

MPD4, Survey No- 378/7&8 379/2&3, Kabra Industrial Estate, Kachigam, Daman (UT) - 396210, India

Tel. No.:

91-260-2244391/92

 

 

Factory  3:

F–13, M.I.D.C., Tarapur, Boisar, District Thane – 401 506, Maharashtra, India 

Tel. No.:

91-2525–661026

 

 

Research Center

26/71 Saug Baug , Marol Industrial Estate, Off Andheri Kurla Road, Andheri (East), Mumbai -400059, Maharashtra, India

Tel. No.:

91 - 22 - 33785924

Fax No.:

91 - 22 - 33785959

 

 

Overseas Office:

2A, Olympic Way, Sefton Business Park, Liverpool, L30 1RD, United Kingdom

Tel. No.:

+44 (0)151 521 4527

Fax. No:

+44 (0)151 521 0140

E-Mail :

suketu@medleypharma.co.uk
jignasu@medleypharma.co.uk

 


 

DIRECTORS

 

As on 31.03.2017

 

Name :

Mr. Sahir Sami Khatib

Designation :

Wholetime Director

Address :

Shoa, Plot No.25, Gulmohar Cross Road No.5, JVPD, Vile Parle (West), Mumbai-400049, Maharashtra, India

Date of Birth/Age :

26.10.1962

Qualification :

BSC, B PHARMA

Date of Appointment :

01.04.2015

PAN No:

AABPK6776G

DIN No:

00043681

 

 

Name :

Mr. Sarosh Sami Khatib

Designation :

Wholetime Director

Address :

Shoa, Plot No.25, Gulmohar Cross Road No.5, JVPD, Vile Parle (West), Mumbai-400049, Maharashtra, India

Date of Birth/Age :

21.02.1964

Qualification :

B PHARM, MMM

PAN No:

AABPK6775F

Date of Appointment :

17.07.1987

DIN No:

00058143

 

 

Name :

Mr. Saba Mir Asif Ali

Designation :

Director

Address :

51, Nupur, Gulmohar Cross Road No.4 JVPD, Vile Parle (West), Mumbai-400049, Maharashtra, India

Date of Birth/Age :

06.02.1959

Qualification :

B.SC. Diploma in Management Studies from NMIM, Computer Programming & Management Applications and Graphic Design

Date of Appointment :

24.02.2015

DIN No:

00058184

 

 

Name :

Mr. Mirasif Mirmohsin Ali

Designation :

Wholetime Director

Address :

51, Nupur, Gulmohar Cross Road No.4 JVPD, Vile Parle (West), Mumbai-400049, Maharashtra, India

Date of Birth/Age :

25.12.1952

Qualification :

MBBS

Date of Appointment :

27.09.1999

DIN No:

00058250

 

Name :

Mr. Mushtaq Ataullah Antulay

Designation :

Director

Address :

Moonlight 158, Maharshi Karve Road, Mumbai-400020, Maharashtra, India

Date of Birth/Age :

24.06.1953

Qualification :

B.A.

Date of Appointment :

14.02.2011

DIN No:

00694678

 

 

Name :

Mr. Suhel Sami Khatib

Designation :

Director

Address :

Shoa, Plot No.25, Gulmohar Cross Road No.5, JVPD, Vile Parle (West), Mumbai-400049, Maharashtra, India

Date of Birth/Age :

10.02.1961

Qualification :

B-Tech (Chem)

Date of Appointment :

01.04.2010

PAN No:

AABPK6779K

DIN No:

00904454

 

 

Name :

Mr. Shuaib Mustafa Fakih

Designation :

Director

Address :

77 / 7, N.S. Patkar Marg, Jahangir Mansion, 3 Rd Floor, Mumbai-400007, Maharashtra, India

Date of Birth/Age :

18.06.1952

Qualification :

Master of Financial Management from Bajaj Institute of Management, Diploma In Operations Research, M.Com

Date of Appointment :

30.06.2012

DIN No:

05267982

 

 

Name :

Mr. Surendra Kumar Ramsanehi Sharma

Designation :

Wholetime Director

Address :

Building No.42, Flat No.202, 2nd Floor 23, Mhada Code No.128, Oshiwara, Mumbai-400102, Maharashtra, India

Date of Birth/Age :

30.06.1958

Qualification :

MSC, MBA

Date of Appointment :

16.08.2017

DIN No:

01204773

 

 

 

KEY EXECUTIVES

 

Name :

Sanjay Dholakia and Associates

Designation :

Company Secretary

Address :

GP-15, Second Floor, Raghuleela Mall, Behind Poinsur Bus Depot, Kandivali (West), Mumbai – 400067, Maharashtra, India

Tel. No:

91-22-28073233

Mob. No:

91-9870031365

Fax. No:

Sanjayrd65@yahh.com

PAN No.:

AABPD0127E

 

 

Name :

Mr. Ravindra Baliram More

Designation :

Company Secretary

Address :

E-303, Rail Nagar Society, Vazira Naka, L T Road, Borivali (West), Mumbai-400092,  Maharashtra, India

Date of Birth/Age :

17.10.1971

Qualification :

CS, LLB(GEN), BCOM

Date of Appointment :

01.12.2014

PAN No.:

AFTPM3830J

 

 

Name :

Mr. Surendra Kumar Ramsanehi Sharma

Designation :

Chief Executive Officer

Address :

Building No.42, Flat No.202, 2nd Floor 23, Mhada Code No.128, Oshiwara, Mumbai-400102, Maharashtra, India

Date of Birth/Age :

30.06.1958

Qualification :

MSC, MBA

Date of Appointment :

16.08.2017

PAN No.:

AAEPS8514M

DIN No:

 

 

 

Name :

Mr. Firdaus Jehangir Tarachand

Designation :

Chief Finance Officer

Address :

102, Luv Apartments Off Veera Desai Road, Andheri (West), Mumbai-400053, Maharashtra, India

Date of Appointment :

10.12.2014

PAN No.:

AANPT5550H

 

 

MAJOR SHAREHOLDERS

 

As on 31.03.2017

 

SHAREHOLDER FILES ARE ATTTACHED

 

Equity Share Break up (Percentage of Total Equity)

 

As on: 30.09.2017

 

Category

Percentage

Promoters (Individual/Hindu Undivided Family – Indian)

96.13

Promoters (Individual/Hindu Undivided Family (Non-resident Indian (NRI))

3.76

Public/Other than promoters (Individual/Hindu Undivided Family – Indian)

0.11

Total 

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturers of dealers in and exporters and importers of all kinds of Pharmaceutical products, drugs, and medical products. (Registered Activity)

 

 

Products / Services :

Item Code No.

Products/Services Description

30045002

Hematinic

30042039

Anti-Infective

30049069

Anti-Inflammatory

30042099

Others

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Available

 

 

Imports :

Not Available

 

 

Terms :

Not Available

 

PRODUCTION STATUS – (NOT AVAILABLE)

 

GENERAL INFORMATION

 

Suppliers :

 

Reference :

Not Available

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

Customers :

 

Reference :

Not Available

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

No. of Employees :

Not Available

 

 

Bankers :

Banker Name :

State Bank of India

Branch :

Singapore Branch, 135, Cecil Street #01-00, Singapore 069536 Singapore

Person Name (With Designation) :

--

Contact Number :

--

Name of Account Holder :

--

Account Number :

--

Account Since (Date/Year of Account Opening) :

--

Average Balance Maintained :

--

Credit Facilities Enjoyed (CC/OD/Term Loan) :

--

Account Operation :

--

Remark :

--

 

  • ICICI Bank Limited, Landmarkrace Cource Circle, Alkapuri, Vadodara – 390015, Gujarat, India

 

  • State Bank of India, Industrial Finance Branch, Snehal Chambers, Teli Gulli, Andheri (East), Mumbai-400069, Maharashtra, India

 

 

Facilities :

Secured Loan

31.03.2017

(INR in Million)

31.03.2016

(INR in Million)

Long-term Borrowings

 

 

Term loans from banks

59.035

140.243

Other loans and advances

1.299

1.828

Short-term borrowings

 

 

Other loans and advances

368.031

330.689

Total

428.365

472.76

 

 

Auditors :

 

Name :

Delloite Haskins and Sells

Chartered Accountants

Address :

Tower 3, 27-32 Floor, Indiabulls Finance Centre, Senapati Bapat Marg, Elphinstone (West) Mumbai-400013, Maharashtra, India

Income-tax PAN of auditor or auditor's firm :

AABFD7919A

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Subsidiaries :

  • Sinkhai Healthcare Limited (U24230MH2005PLC151938)
  • Blue-Fin Frozen Foods Private Limited (U15139MH2008PTC188502)
  • Medley Pharma Limited

 

 

CAPITAL STRUCTURE

 

As on: 31.03.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

66000000

Equity Shares

INR 5/- each

INR 330.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

63874000

Equity Shares

INR 5/- each

INR 319.370 Million

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are INR Million]

 

ABRIDGED BALANCE SHEET (STANDALONE)

 

SOURCES OF FUNDS

 

31.03.2017

31.03.2016

31.03.2015

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

319.370

319.370

319.370

(b) Reserves & Surplus

2902.325

2405.194

2184.989

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

3221.695

2724.564

2504.359

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

60.334

142.071

170.452

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

73.241

60.470

61.095

(d) long-term provisions

52.079

44.387

102.816

Total Non-current Liabilities (3)

185.654

246.928

334.363

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

464.431

670.689

569.897

(b) Trade payables

728.717

664.180

520.582

(c) Other current liabilities

175.774

184.652

251.581

(d) Short-term provisions

42.805

42.973

105.272

Total Current Liabilities (4)

1411.727

1562.494

1447.332

 

 

 

 

TOTAL

4819.076

4533.986

4286.054

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

1945.311

1495.819

1408.942

(ii) Intangible Assets

7.982

12.785

9.171

(iii) Capital work-in-progress

6.048

513.855

439.877

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

360.962

311.428

316.385

(c) Deferred tax assets (net)

10.965

8.019

10.452

(d)  Long-term Loan and Advances

326.047

175.507

180.356

(e) Other Non-current assets

5.991

5.652

5.304

Total Non-Current Assets

2663.306

2523.065

2370.487

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

52.427

43.772

0.000

(b) Inventories

672.103

694.445

753.728

(c) Trade receivables

1041.891

1000.889

852.577

(d) Cash and cash equivalents

108.515

17.504

49.007

(e) Short-term loans and advances

279.724

253.176

258.385

(f) Other current assets

1.110

1.135

1.870

Total Current Assets

2155.770

2010.921

1915.567

 

 

 

 

TOTAL

4819.076

4533.986

4286.054

 

 

PROFIT & LOSS ACCOUNT (STANDALONE)

 

 

PARTICULARS

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

Income

5523.278

4997.640

4604.874

 

Other Income

50.565

26.415

42.597

 

TOTAL

5573.843

5024.055

4647.471

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

894.559

856.853

918.683

 

Purchases of Stock-in-Trade

1173.766

955.552

961.620

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

34.262

15.994

(167.839)

 

Employees benefits expense

1313.460

1364.524

1190.556

 

CSR Expenditure

10.100

8.000

8.500

 

Other expenses

1234.294

1124.961

1003.201

 

TOTAL

4660.441

4325.884

3914.721

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

913.402

698.171

732.750

 

 

 

 

 

Less

FINANCIAL EXPENSES

52.835

78.469

49.789

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

860.567

619.702

682.961

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

128.976

117.712

123.779

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

731.591

501.990

559.182

 

 

 

 

 

Less

TAX

234.460

166.470

94.842

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

497.131

335.520

464.340

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

F.O.B. Value of Exports

760.581

758.194

616.846

 

TOTAL EARNINGS

760.581

758.194

616.846

 

 

 

 

 

 

IMPORTS

 

 

 

 

Raw Materials

93.268

98.223

60.685

 

Capital Goods

2.813

23.037

15.220

 

TOTAL IMPORTS

96.081

121.260

75.905

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

7.78

5.25

7.27

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

79.599

81.904

69.132

Cash generated from operations

917.465

725.626

351.039

Net cash flows from (used in) operating activity

683.097

565.610

217.505

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

(Sundry Debtors / Income * 365 Days)

68.85

73.10

67.58

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

5.30

4.99

5.40

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

128.60

133.76

101.05

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

1.36

1.01

0.97

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

0.47

0.35

0.39

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.32

0.39

0.39

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.19

0.33

0.32

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

0.44

0.57

0.58

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.61

0.74

0.74

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

17.29

8.90

14.72

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Net Profit Margin

((PAT / Sales) * 100)

%

9.00

6.71

10.08

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

10.32

7.40

10.83

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

15.43

12.31

18.54

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

1.53

1.29

1.32

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

1.05

0.84

0.80

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.67

0.60

0.58

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

1.89

2.80

2.53

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

1.53

1.29

1.32

 

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Share Capital

319.370

319.370

319.370

Reserves & Surplus

2184.989

2405.194

2902.325

Net worth

2504.359

2724.564

3221.695

 

 

 

 

long-term borrowings

170.452

142.071

60.334

Short term borrowings

569.897

670.689

464.431

Current maturities of long-term debts

69.132

81.904

79.599

Total borrowings

809.481

894.664

604.364

Debt/Equity ratio

0.323

0.328

0.188

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

4604.874

4997.640

5523.278

 

 

8.529

10.518

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

4604.874

4997.640

5523.278

Profit

464.340

335.520

497.131

 

10.08%

6.71%

9.00%

 

 

 

 

 

ABRIDGED BALANCE SHEET (CONSOLIDATED)

 

SOURCES OF FUNDS

31.03.2017

31.03.2016

 

 

 

I.              EQUITY AND LIABILITIES

 

 

(1)Shareholders' Funds

 

 

(a) Share Capital

319.370

319.370

(b) Reserves & Surplus

2777.470

2336.172

(c) Money received against share warrants

0.000

0.000

 

 

 

(2) Minority Interest

75.762

61.126

Total Shareholders’ Funds (1) + (2)

3172.602

2716.668

 

 

 

(3) Non-Current Liabilities

 

 

(a) long-term borrowings

85.333

165.497

(b) Deferred tax liabilities (Net)

0.000

0.000

(c) Other long term liabilities

123.509

116.673

(d) long-term provisions

54.913

46.480

Total Non-current Liabilities (3)

263.755

328.650

 

 

 

(4) Current Liabilities

 

 

(a) Short term borrowings

830.510

987.785

(b) Trade payables

861.406

732.624

(c) Other current liabilities

206.157

246.010

(d) Short-term provisions

48.912

47.198

Total Current Liabilities (4)

1946.985

2013.617

 

 

 

TOTAL

5383.342

5058.935

 

 

 

II.          ASSETS

 

 

(1) Non-current assets

 

 

(a) Fixed Assets

 

 

(i) Tangible assets

2240.826

1812.067

(ii) Intangible Assets

83.383

112.235

(iii) Capital work-in-progress

6.048

513.855

(iv) Intangible assets under development

3.920

0.000

(b) Non-current Investments

0.132

0.132

(c) Deferred tax assets (net)

10.965

8.019

(d)  Long-term Loan and Advances

334.150

182.523

(e) Other Non-current assets

5.991

5.652

Total Non-Current Assets

2685.415

2634.483

 

 

 

(2) Current assets

 

 

(a) Current investments

52.427

43.772

(b) Inventories

974.776

920.253

(c) Trade receivables

1186.442

1099.236

(d) Cash and cash equivalents

143.121

63.671

(e) Short-term loans and advances

339.743

296.205

(f) Other current assets

1.418

1.315

Total Current Assets

2697.927

2424.452

 

 

 

TOTAL

5383.342

5058.935

 

 

PROFIT & LOSS ACCOUNT (CONSOLIDATED)

 

 

PARTICULARS

31.03.2017

31.03.2016

 

SALES

 

 

 

Income

6,744.083

5938.674

 

Other Income

44.249

31.671

 

TOTAL

6788.332

5970.345

 

 

 

 

Less

EXPENSES

 

 

 

Cost of Materials Consumed

1862.356

1587.810

 

Purchases of Stock-in-Trade

1226.393

989.588

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(43.012)

(61.269)

 

Employees benefits expense

1408.114

1438.044

 

CSR Expenditure

10.100

8.000

 

Prior Period

0.000

3.225

 

Other expenses

1393.711

1234.834

 

TOTAL

5857.662

5200.232

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

930.670

770.113

 

 

 

 

Less

FINANCIAL EXPENSES

74.090

97.052

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

856.580

673.061

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

164.471

158.302

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

692.109

514.759

 

 

 

 

Less

TAX

241.237

173.006

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

450.872

341.753

 

 

 

 

Add

SHARE OF PROFIT (LOSS) OF ASSOCIATES

(14.636)

(25.507)

 

 

 

 

 

NET PROFIT

436.236

316.246

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

6.83

4.95

 

 

LEGALS FILE

 

Case Details

 

Bench:-Bombay

 

Presentation Date:-

15/05/2017

Lodging No.:-

ITXAL/1199/2017

Filing Date:-

15/05/2017

Reg. No.:-

ITXA/1226/2017

Reg. Date:-

01/09/2017

 

 

Petitioner:-

PR. COMMISSIONER OF INCOME TAX - 10

Respondent:-

MEDLEY PHARMACEUTICALS LIMITED

 

Petn.Adv.:-

AKHILESHWAR SHARMA (827)

Resp.Adv.:-

D M HARISH AND COMPANY (I8165)

 

District:-

MUMBAI

 

 

Bench:-

DIVISION

Status:-

Pre-Admission

Category:-

TAX APPEALS

 

Next Date:-

25/04/2018

Stage:-

FOR REJECTION [ORIGINAL SIDE MATTERS]

 

Coram:-

ACCORDING TO SITTING LIST

 

ACCORDING TO SITTING LIST

 

 

Act :-

Income Tax Act, 1961

Under Section:-

260 A

 

Case Details

 

Bench:-Bombay

 

Presentation Date:-

25/01/2017

Lodging No.:-

ITXAL/257/2017

Filing Date:-

25/01/2017

Reg. No.:-

ITXA/510/2017

Reg. Date:-

23/03/2017

 

 

Petitioner:-

PR. COMMISSIONER OF INCOME TAX - 10

Respondent:-

MEDLEY PHARMACEUTICALS LIMITED

 

Petn.Adv.:-

AKHILESHWAR SHARMA (827)

Resp.Adv.:-

D M HARISH AND COMPANY (I8165)

 

District:-

MUMBAI

 

 

Bench:-

DIVISION

Status:-

Pre-Admission

Category:-

TAX APPEALS

 

Next Date:-

19.03.2018

Stage:-

--

 

Coram:-

ACCORDING TO SITTING LIST

 

ACCORDING TO SITTING LIST

 

 

Act :-

Income Tax Act, 1961

Under Section:-

260 A

 

Case Details

 

Bench:-Bombay

 

Presentation Date:-

25/01/2017

Lodging No.:-

ITXAL/258/2017

Filing Date:-

25/01/2017

Reg. No.:-

ITXA/511/2017

Reg. Date:-

21.03.2017

 

 

Petitioner:-

PR. COMMISSIONER OF INCOME TAX - 10

Respondent:-

MEDLEY PHARMACEUTICALS LIMITED

 

Petn.Adv.:-

AKHILESHWAR SHARMA (827)

Resp.Adv.:-

D M HARISH AND COMPANY (I8165)

 

District:-

MUMBAI

 

 

Bench:-

DIVISION

Status:-

Pre-Admission

Category:-

TAX APPEALS

 

Next Date:-

19.03.2018

Stage:-

--

 

Coram:-

ACCORDING TO SITTING LIST

 

ACCORDING TO SITTING LIST

 

 

Act :-

Income Tax Act, 1961

Under Section:-

260 A

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

No

8

Designation of contact person

No

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last two/ three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

Yes

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

Yes

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

STATE OF AFFAIRS/ PERFORMANCE:

 

During the year, the Company revenue from operations stood at INR 5523.279 Million as against INR 4997.640 Million in the previous year. The Company has earned a Net profit of INR 496.873 Million as compared to the Profit of INR 335.520 Million during the previous accounting year.

 

 

UNSECURED LOAN

 

PARTICULARS

31.03.2017

(INR in Million)

31.03.2016

(INR in Million)

Short-term borrowings

 

 

Rupee term loans from banks

30.000

290.000

Loans and advances from related parties

66.400

50.000

Total

96.400

340.000

 

INDEX OF CHARGES

 

SNo

SRN

Charge Id

Charge Holder Name

Date of Creation

Date of Modification

Date of Satisfaction

Amount

Address

1

C65196206

10561110

ICICI BANK LIMITED

30/03/2015

10/09/2015

-

65000000.0

LANDMARKRACE COURCE CIRCLEALKAPURIBARODAGJ390015IN

2

B71464135

10388032

State Bank of India

06/11/2012

11/03/2013

-

312500000.0

Singapore Branch, 135, Cecil Street #01-00SingaporeSingaporeNA069536SG

3

C76894534

10165956

ICICI BANK LIMITED

20/05/2009

12/01/2016

-

250000000.0

LANDMARKRACE COURCE CIRCLEALKAPURIBARODAGJ390015IN

4

A98044092

90240567

STATE BANK OF INDIA

31/03/1999

01/11/2010

-

173000000.0

INDUSTRIAL FINANCE BRANCH, SNEHAL CHAMBERSTELI GULLI, ANDHERI (EAST)MUMBAIMH400069IN

5

C57561425

10304448

State Bank of India

08/07/2010

-

09/06/2015

20000000.0

M.I.D.C ANDHERI (E) BRANCH, PLOT NO. B-1,CENTRAL ROAD, ANDHERI (E),MUMBAIMH400093IN

6

B94601804

10088386

3i Infotech Trusteeship Services Limited

15/01/2008

-

24/01/2014

80000000.0

3rd to 6th floor, International Infotech Park,Tower No.5, Vashi Railway Station Complex, VashiNavi MumbaiMH400703IN

7

B90787078

90240433

STATE BANK OF INDIA

09/02/1998

01/11/2010

21/11/2013

15000000.0

INDUSTRIAL FINANCE BRANCH, SNEHAL CHAMBERSTELI GULLI, ANDHERI (EAST)MUMBAIMH400069IN

8

B89718530

90243549

STATE BANK OF INDIA

27/12/2001

01/11/2010

28/10/2013

50400000.0

INDUSTRIAL FINANCE BRANCH, SNEHAL CHAMBERSTELI GULLI, ANDHERI (EAST)MUMBAIMH400069IN

9

B63445563

10037210

ICICI BANK LIMITED

21/12/2006

30/01/2009

23/11/2012

180000000.0

LANDMARKRACE COURCE CIRCLEALKAPURIBARODAGJ390015IN

10

B26434266

10005652

ICICI BANK LIMITED

20/03/2006

-

16/11/2011

65000000.0

LANDMARKRACE COURCE CIRCLEALKAPURIBARODAGJ390015IN

 

 

 

FIXED ASSETS

 

Tangible assets

  • Land
  • Residential building
  • Plant and equipment
  • Furniture and fixtures
  • Vehicles
  • Office equipment
  • Computer equipment’s

Intangible assets

  • Brands and trade marks
  • Trade marks     
  • Computer software

 

 

 

 

 

 

 

 

 

 

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 63.35

UK Pound

1

INR 85.89

Euro

1

INR 76.16

 

 

INFORMATION DETAILS

 

Analysis Done by :

NYT

 

 

Report Prepared by :

MTN

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

YES

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.